Chemical name: 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
Formula: C28H38N6O11S
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

SILDIGRA CT 7 CHEWABLE

Description: SILDIGRA CT 7 CHEWABLE, manufactured by Dharam Distributors, is a pharmaceutical product designed to address erectile dysfunction (ED) in men. Each package contains 7 chewable tablets, each containing 100 mg of the active substance Sildenafil. SILDIGRA CT 7 CHEWABLE offers men a convenient and discreet solution to restore erectile function, allowing for improved sexual performance and satisfaction.

Active Substance: The active substance in SILDIGRA CT 7 CHEWABLE is Sildenafil, a potent phosphodiesterase type 5 (PDE5) inhibitor used for the treatment of erectile dysfunction. Sildenafil works by enhancing the effects of nitric oxide, a chemical that relaxes smooth muscles in the penis, thereby increasing blood flow and facilitating erections.

Indications: SILDIGRA CT 7 CHEWABLE is indicated for the treatment of erectile dysfunction (ED) in adult men. Erectile dysfunction is defined as the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.

Mechanism of Action: Sildenafil exerts its pharmacological effects by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. By inhibiting PDE5, Sildenafil prolongs the action of cGMP, leading to smooth muscle relaxation, vasodilation, and increased blood flow to the penis, thereby facilitating erections.

Benefits:

• Improved Erectile Function: SILDIGRA CT 7 CHEWABLE helps men achieve and maintain firm erections suitable for sexual intercourse, enhancing sexual performance and satisfaction.
• Rapid Onset of Action: The chewable formulation of SILDIGRA CT 7 allows for faster absorption and onset of action compared to traditional oral tablets, allowing for more spontaneous sexual activity.
• Convenient Administration: SILDIGRA CT 7 CHEWABLE offers a convenient and discreet option for men who prefer a chewable dosage form over traditional tablets or capsules.

How to Use: SILDIGRA CT 7 CHEWABLE tablets are chewed and swallowed, typically 30 minutes to 1 hour before anticipated sexual activity. The tablet should be taken with a glass of water, and food intake may delay the onset of action. It is essential to follow the prescribing healthcare provider’s instructions regarding dosage and timing of administration.

Dosage: The recommended dosage of SILDIGRA CT 7 CHEWABLE is one tablet (100 mg) taken as needed, approximately 30 minutes to 1 hour before sexual activity. The maximum recommended dose is one tablet per day. Dosage adjustments may be made based on individual response and tolerance to the medication.

Efficacy: Clinical studies and extensive clinical experience have demonstrated the efficacy of Sildenafil in improving erectile function and enhancing sexual performance in men with erectile dysfunction. Its well-tolerated profile and rapid onset of action make it a preferred option for the management of this common sexual dysfunction.

Storage: SILDIGRA CT 7 CHEWABLE tablets should be stored at room temperature, away from moisture, heat, and direct sunlight. It is essential to keep the tablets in their original packaging and to ensure that the container is tightly closed when not in use. Unused tablets should be disposed of properly according to local regulations.

Side Effects: Common side effects of SILDIGRA CT 7 CHEWABLE may include headache, flushing, indigestion, nasal congestion, and dizziness. Less common but more serious side effects may include priapism (prolonged erection), sudden vision loss, and allergic reactions. Patients should be monitored for adverse effects, and any concerning symptoms should be reported to the healthcare provider promptly.

Precautions: Certain precautions should be observed when using SILDIGRA CT 7 CHEWABLE:

• SILDIGRA CT 7 CHEWABLE is contraindicated in individuals with a history of hypersensitivity to Sildenafil or any component of the formulation.
• Patients with pre-existing cardiovascular disease or risk factors for cardiovascular events should use SILDIGRA CT 7 CHEWABLE with caution and under medical supervision.
• Use of SILDIGRA CT 7 CHEWABLE may be contraindicated or require dose adjustments in patients taking certain medications, such as nitrates or alpha-blockers, due to the risk of hypotension.

In summary, SILDIGRA CT 7 CHEWABLE by Dharam Distributors offers an effective and convenient solution for men experiencing erectile dysfunction. With its well-established efficacy, rapid onset of action, and chewable formulation, SILDIGRA CT 7 CHEWABLE helps men regain confidence and enjoy satisfying sexual relationships.